The cancer vaccine sipuleucel-T -- now commercially branded as Provenge -- will soon be available at a select group of medical centers nationwide, including UCSF.
March 16, 2010
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation of inhibitory drugs offers promise in correcting this defect.
July 27, 2009
June Chan, who specializes in the study of nutritional and hormonal risk factors for prostate cancer, has been named the Steven and Christine-Burd Safeway Endowed Chair.